---
tags: [gsdose]
max_turns: 40
timeout_seconds: 1200
allowed_tools: [Read, Glob, Grep, Skill, Write, Edit, Bash]
---

Our seamless phase 2/3 oncology trial has reached its second efficacy interim (IA3) and I need the analysis done with the gsDose R package (installed, with gsDesign2 and jsonlite; R and Python are available): update the efficacy boundary at the actual event counts, then compute the combination test statistics and run the closed testing. I can't do back-and-forth, so here is everything — don't ask questions, just proceed:

- 3 dose arms vs control; dose 2 was selected at the dose-selection interim (IA1). Endpoint OS. Three testing analyses: IA2, IA3, FA (IA1 not counted). One-sided alpha 0.025, O'Brien-Fleming spending, no futility bound. Planned FA events (selected dose + control, both cohorts): 520.
- Cohort weights h = (sqrt(60/700), sqrt(640/700)) at every analysis. Pre-specified stage weights w from the design: IA2 row (1, 0, 0); IA3 row (0.8992, 0.4375, 0); FA row (0.8499, 0.4136, 0.3265). Randomization 1:1.
- Actual events (selected dose + control, both cohorts): IA2 occurred at 270 events (231 from cohort 2); IA3 occurred at 430 events (385 from cohort 2).
- Observed cohort-1 log-rank z statistics (each dose arm vs control, all three arms): IA2 (0.8, 1, 0.7); IA3 (0.9, 1.2, 0.81). Cohort-1 cumulative events per dose-arm-vs-control comparison: IA2 (40, 36, 38); IA3 (51, 42, 49). Cohort-2 log-rank z for dose 2 at IA3: 2.35.

Deliver the full bundle: a Word report that includes the closed-testing results, one combined JSON of all results, and a standalone R script that reproduces the boundary and the test statistics.
